Ask most brand owners whether their magnesium supplement is BPOM-ready and they will point to the mineral itself, magnesium is safe, magnesium is widely sold, magnesium is on the list. That is usually true, but it is rarely the thing that actually stalls a filing.
What we see stall applications is the compound form sitting behind the label. Annex VII of Peraturan BPOM No. 32/2022, as amended by Peraturan BPOM No. 15/2024, sets maximum daily intake limits for magnesium as an element, but not every organic salt used by modern formulators is named in the published gazette.
When a compound such as magnesium L-threonate is missing from that list, reviewers ask for a supplementary safety dossier on the exact salt, not a generic magnesium justification, and that single request can add two to four months to an otherwise routine timeline. This piece walks supplement brand owners, importers, and regulatory affairs teams through the five magnesium compound forms sold in Indonesia, where each stands under BPOM’s ingredient list, and what health supplement registration and BPOM certification actually involve before a magnesium supplement reaches the shelf.
What Counts as a Magnesium Supplement Under Indonesian Regulation
Under Peraturan BPOM No. 32 of 2022 concerning Criteria and Procedures for Health Supplement Registration, a health supplement is defined as a product intended to complement nutritional needs and maintain or support health functions, containing vitamins, minerals, amino acids, or other substances at levels beyond ordinary food. A magnesium supplement is classified under the mineral category of this definition.
Magnesium products can legally be sold in Indonesia as powders, tablets, capsules, chewable gummies, effervescent tablets, oral gels, or liquids. Dosage form and quality parameters for these formats are set out in Peraturan BPOM No. 24 of 2023 concerning Safety and Quality Requirements of Health Supplements, which every registered magnesium product must meet.
Magnesium is only one mineral among many that fall under this same classification. If you are weighing how a broader vitamin or mineral line would be categorized, our Health Supplement Registration Indonesia guide walks through how BPOM classifies each ingredient type before filing.
The 5 Types of Magnesium Supplements Sold in Indonesia
Indonesian consumers can buy several magnesium compound forms, each carrying a different position under BPOM’s Positive List and, in turn, a different registration path. The five below account for the majority of magnesium supplement filings we see move through evaluation.
Magnesium Oxide: The Positive List’s Most Established Entry
Magnesium oxide has one of the longest-standing entries on the Positive List in Annex VII of Peraturan BPOM No. 32/2022, which is why it is also the most common and least expensive magnesium salt sold in Indonesia. It carries a high proportion of elemental magnesium by weight but is absorbed less efficiently than other forms, and is typically marketed for general daily supplementation and occasional constipation relief.
Magnesium Citrate: A Separately Listed Compound Under the Same Framework
Magnesium citrate combines magnesium with citric acid and, despite the shared mineral, is evaluated as its own entry in Annex VII rather than inheriting oxide’s listing. Its higher solubility makes it a frequent choice for powder and liquid formats, and quality parameters for these formats fall under Peraturan BPOM No. 24 of 2023 on safety and quality requirements.
Magnesium Glycinate: Where a Mineral and an Amino Acid Meet
Magnesium glycinate binds magnesium to the amino acid glycine, which means a filing has to satisfy the mineral limit for magnesium and the amino acid parameters for glycine at the same time. This dual composition is a common reason reviewers request compound-specific documentation beyond a standard magnesium justification, even though the product is marketed simply as a sleep or stress-support supplement.
Magnesium L-Threonate: A Compound the Positive List May Not Yet Name
Magnesium L-threonate is a newer compound formulated to cross the blood-brain barrier and is typically marketed for cognitive or memory-support claims. It is the form most likely to sit outside the version of Annex VII currently published under Peraturan BPOM No. 15/2024, which triggers the supplementary safety dossier pathway described earlier in this article.
Magnesium Sulfate and Magnesium Hydroxide: A Classification Question Before a Registration Question
Magnesium sulfate and magnesium hydroxide are used in short-term digestive products and topical applications such as bath salts. Because Peraturan BPOM No. 32/2022 defines a health supplement by its intended nutritional and functional role, a laxative-focused or topical use can push these products toward a different regulatory category entirely, which needs to be settled before registration begins.
| Magnesium Type | Typical Consumer Use | Elemental Magnesium Yield | BPOM Registration Note |
|---|---|---|---|
| Magnesium Oxide | General daily supplementation, constipation relief | High by weight, lower absorption | Long-listed on the Positive List; most predictable filing |
| Magnesium Citrate | Daily supplementation, occasional constipation relief | Moderate, higher absorption than oxide | Listed compound; claims wording is the main review point |
| Magnesium Glycinate | Sleep support, stress-related marketing claims | Lower by weight, high absorption | Compound-specific documentation is often requested |
| Magnesium L-Threonate | Cognitive and memory-support formulations | Low by weight, formulated for absorption | May fall outside the published Positive List; longer review |
| Magnesium Sulfate / Hydroxide | Short-term digestive or topical (bath salt) use | Variable, use-dependent | Category classification affects whether it is a supplement at all |
How Do You Register a Magnesium Supplement With BPOM in Indonesia?
Registering a magnesium supplement with BPOM requires confirming the product’s classification as a health supplement under BPOM, verifying that the specific magnesium compound and its dosage appear on the Positive List in Annex VII, and submitting a registration dossier covering formulation, labeling, manufacturing evidence, and safety data through BPOM’s electronic registration system before any distribution or advertising can legally begin.
Health Supplement Registration Process for a Magnesium Product
The stages below outline how a magnesium supplement typically moves through BPOM’s registration pathway. Because outcomes depend on formulation specifics, this overview is not a substitute for a formulation-specific regulatory assessment.
- Confirm product classification as a health supplement rather than a food, drug, or quasi-drug.
- Check the exact magnesium compound and daily dose against the Positive List
- Compile manufacturing evidence consistent with Peraturan BPOM No. 24 of 2023 on safety and quality requirements.
- Prepare labeling and claims in Bahasa Indonesia consistent with permitted health supplement claim wording.
- Submit the registration dossier through BPOM’s registration system and respond to any evaluator queries, including compound-specific requests.
- Maintain post-market compliance once the registration number (NIE) is issued, including monitoring obligations.
This is roughly where a filing turns from paperwork into judgment calls, deciding how a borderline compound should be classified, or how a claim should be worded, and it is the part our Health Supplements Registration service is built around, working through each stage alongside a manufacturer’s own filing team.
BPOM Certification vs Notification for Supplement Products
Health supplements, including magnesium products, go through BPOM’s pre-market registration and evaluation process rather than the lighter notification pathway used for some cosmetic categories. Government Regulation No. 86 of 2019 on food safety underpins the broader safety framework BPOM applies during this evaluation.
Good manufacturing and facility compliance are assessed alongside the product file itself. Foreign manufacturers are generally expected to demonstrate facility standards consistent with BPOM’s expectations, which is one reason many international brands work through a locally established registration structure rather than filing independently.
Positive List Mistakes: Assuming One Compound’s Approval Covers Another
Annex VII of Peraturan BPOM No. 32/2022, as amended by Peraturan BPOM No. 15/2024, evaluates each magnesium salt on its own listing status, not the mineral as a whole. A brand that has previously registered magnesium citrate sometimes assumes magnesium glycinate or L-threonate will move through evaluation the same way, and files without checking that compound’s specific entry first.
Dosage Mistakes: Elemental Magnesium vs Compound Weight
The maximum daily intake limits in Annex VII are set on elemental magnesium, not on the weight of the compound as sold. A formulation built around a round number of the salt itself, for example 500 mg of magnesium citrate per serving, can unintentionally exceed the elemental limit once the conversion is done.
Claims and Labeling Mistakes Under Peraturan BPOM No. 31/2018
Peraturan BPOM No. 31 of 2018 sets the permitted scope of claims and the Bahasa Indonesia labeling requirements that apply to registered food and supplement products. Cognitive, mood, or disease-related claims are a frequent source of rejection when the product’s classification and supporting evidence only justify a general nutritional-support statement, and a directly translated export label rarely matches the accepted local phrasing.
Manufacturing Evidence Mistakes Under Peraturan BPOM No. 11/2020
Peraturan BPOM No. 11 of 2020 governs the good manufacturing practice and facility compliance evidence BPOM expects during evaluation. Products that blend magnesium with zinc, B6, or other minerals need manufacturing and safety evidence covering the full formulation, not just the magnesium component, and gaps here are a common reason combination products get sent back for more documentation.
Applicant and Local Entity Mistakes
A BPOM registration number under Peraturan BPOM No. 32/2022 is held by a locally responsible applicant, whether that is the manufacturer’s own Indonesian entity or a license holder acting on its behalf. A foreign brand that starts building its dossier before this structure is confirmed cannot lodge a valid application, regardless of how complete the technical file is.
A Few Filings We’ve Seen Play Out
A Cognitive-Support Gummy Built Around an Unlisted Compound
A brand developing a magnesium L-threonate gummy assumed the compound would be treated like the magnesium citrate product it had registered a year earlier. Because the specific salt was not named in the published Positive List, BPOM requested a supplementary safety dossier before evaluation could continue, adding roughly three months to the timeline. The product was ultimately approved, but only after the compound-specific documentation was compiled from scratch mid-review.
A Multi-Mineral Capsule That Miscounted Its Own Dosage
A combination capsule containing magnesium, zinc, and vitamin B6 was formulated around 500 mg of magnesium citrate per serving. Once converted to elemental magnesium, the dose exceeded the Annex VII maximum, and the applicant was asked to reformulate before resubmitting. Recalculating elemental content against the Positive List before finalizing the formula would have avoided the extra cycle.
A Brand That Tried to File Before It Had Somewhere to File From
An overseas magnesium supplement brand started preparing its registration dossier before confirming how it would hold a BPOM registration number in Indonesia. Without a local entity or license holder arrangement, the application could not be lodged. The brand later moved forward through a license holder structure, which allowed the same dossier to be submitted successfully.
Avoid the Rework, Not Just the Rejection
Every mistake in this article is fixable after the fact, but every fix costs weeks or months that a straightforward filing would not have needed. A cognitive-claim gummy, a miscalculated dose, or a missing local entity are rarely fatal to a magnesium supplement launch, but they are expensive in time.
If you would rather confirm your compound, dose, and claims are correct before submission than untangle an evaluator query afterward, our Health Supplements Registration team can review your formulation and build a filing strategy suited to your specific product before you file.
